Welcome to our consulting company Consultio!
ScieGen PharmaceuticalsScieGen PharmaceuticalsScieGen Pharmaceuticals
Call Us
New York 11788

Management

  • Dr. Pailla Malla Reddy
  • Tab Title 2
  • Tab Title 3

Dr. Pailla Malla Reddy

Dr. Pailla Malla Reddy is a successful pharmaceutical entrepreneur with over 30 years of experience in the industry. He began his career working in various positions in pharmaceutical companies in India, Nigeria, and the United States. In 1995, Dr. Reddy founded Bactolac Pharmaceutical Inc, which is known today as an industry leading contract manufacturer of vitamins and supplements. He went on to found ScieGen Pharmaceuticals, Inc. in 2009. Under Dr. Reddy's eminent leadership, ScieGen continues to grow and become a leader in the generic manufacturing space. Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Optio, neque qui velit. Magni dolorum quidem ipsam eligendi, totam, facilis laudantium cum accusamus ullam voluptatibus commodi numquam, error, est. Ea, consequatur.

Dr. Pailla Malla Reddy

CEO

Siva Reddy Palempalli

COO

Subba Reddy Vattigunta 

Associate Vice President

Dr. Raghuram Pannala

Head, CQC , RA & PV

Krishna Chilakamarthy

Sr. Director Quality Control

Bala Murali K Nagisetti

Associate Director Quality Assurance

Brett Barczak

Senior Vice President, Sales & Marketing

Saketh Reddy

Director, Sales & Marketing

Dr. Pailla Malla Reddy

CEO
Dr. Pailla Malla Reddy is a successful pharmaceutical entrepreneur with over 30 years of experience in the industry. He began his career working in various positions in pharmaceutical companies in India, Nigeria, and the United States. In 1995, Dr. Reddy founded Bactolac Pharmaceutical Inc, which is known today as an industry leading contract manufacturer of vitamins and supplements. He went on to found ScieGen Pharmaceuticals, Inc. in 2009. Under Dr. Reddy's eminent leadership, ScieGen continues to grow and become a leader in the generic manufacturing space.

Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.

Siva Reddy Palempalli

COO
Mr. Reddy serves as Chief Operating Officer, bringing over two and a half decades of experience in the pharmaceutical industry in new product development, pre-formulations, analytical R&D, and regulatory submissions. Before joining ScieGen, Mr. Reddy served as Associate Vice President at Aurobindo Pharma Limited in India, overseeing the research center in handling all kinds of sterile formulations. He has significant experience in solid oral dosages, liquids, and parenterals. Mr. Reddy also spent over 12 years with Dr. Reddy’s Laboratories as the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, and EU drug filings throughout the USA, Canada, and Europe and has several patents (the US and WO). He has also written several publications.

Mr. Reddy holds an MS degree in Pharmacy from Dr. MGR Medical University in India.

Subba Reddy Vattigunta

Associate Vice President
Subba Reddy is the Associate Vice President and Head of Manufacturing Operations. He is responsible for the manufacturing and supply of pharmaceutical products, and leads a team of over 250 employees.

Mr. Reddy joined ScieGen in October, 2016 as Senior Director, and has extensive manufacturing background in achieving significant performance improvement with regards to deliveries, projects, and safety. Prior to joining ScieGen, Mr. Reddy worked as a Manufacturing Plant Site Head at Dr. Reddy’s Laboratories, Head of Operations at Wockhardt, and Head of Production at Cipla.

He has over 30 years of experience in the industry, and holds a Bachelor's Degree in Pharmacy and management leadership certifications.

Dr. Raghuram Pannala

Head, CQC , RA & PV
Dr P. Raghu Ram leads the Regulatory Affairs and Compliance teams at ScieGen. He has over 27 years of experience in the pharmaceutical industry, in the areas of Analytical Development, Quality Control Quality Assurance, Regulatory Compliance, and Pharmacovigilance. Dr. Ram had published 24 research publications during his career. He is a member of IPC {Indian Pharmacopeial Commission} and USP {United States Pharmacopeia} 2005-2010 monographs acquisition committee He is contributing author for PDA FDA Technical report – 80 , ‘Data Integrity Management System for Pharmaceutical Laboratories and sub team lead in PDA Remote Audits & Inspections Team, PDA COVID-19 PtC Task Force.

Dr. Ram holds a Ph.D in Analytical Chemistry from Sri Krishnadevaraya University in India. He holds certifications such as a CQA {Certified Quality Auditor} and CMQ/OE {Certified manager for Organizational Excellence} from ASQ {American Society for Quality}, Statistical Quality Control diploma from Indian Statistical institute.

Krishna Mohan Chilakamarthy

Sr. Director Quality Control
Krishna Mohan Chilakamarthy, Senior Director of Quality Control, has 25 years of experience in the pharmaceutical industry. Krishna first joined ScieGen in July, 2013 as the Head of Quality Control, handling all the development & commercial activities of the QC department. Prior to joining ScieGen, Krishna was the Analytical Head at Halo Pharmaceuticals, a contract research and manufacturing company. He also held various positions at Par Pharmaceuticals and Dr. Reddy’s Laboratories.

Bala Murali K Nagisetti

Associate Director Quality Assurance
Mr. Bala Murali K Nagisetti, Associate Director of Quality Assurance, joined ScieGen in March 2014. Mr. Bala is responsible for ensuring the compliance of FDA regulations and current Good Manufacturing Practices at ScieGen

Mr. Bala has about 24 years of experience in the pharmaceutical industry. Prior to joining ScieGen, he worked with Dr. Reddy’s Laboratories and Apotex Inc.

Mr. Bala is a chemistry postgraduate from Rajasthan Vidyapeet University, India

Brett Barczak

Senior Vice President, Sales & Marketing
Brett joined ScieGen in May, 2019, as SVP of Sales and Marketing. Mr. Barczak is an industry veteran who brings 30+ years’ experience, in both purchasing and sales to ScieGen. He held positions as Purchasing Manager at Moore Medical Corp., and VP of Purchasing at Harvard Drug for several years, before transitioning to sales. Brett’s sales experience includes stints with Bi-Coastal Pharmaceutical Corp., Able Labs, Genpharm L.P., and Camber Pharmaceuticals, where he was hired as Camber’s first salesperson.

Saketh Reddy

Director, Sales & Marketing
Saketh joined ScieGen in July, 2020 as the Director of Sales and Marketing. Prior to this role, he held the position of Sales and Marketing Manager at Akron Generics, a pharmaceutical wholesale distributor. Mr. Reddy also sits on the Board of Directors of Bactolac Pharmaceutical.

He holds a BS degree in Business from Texas A&M University.
Dr. PaillaMalla Reddy is a successful pharmaceutical entrepreneur with over 30 years of experience in the industry. He began his career working in various positions in pharmaceutical companies in India, Nigeria, and the United States. In 1995, Dr. Reddy founded Bactolac Pharmaceutical Inc, which is known today as an industry leading contract manufacturer of vitamins and supplements. He went on to found ScieGen Pharmaceuticals, Inc. in 2009. Under Dr. Reddy's eminent leadership, ScieGen continues to grow and become a leader in the generic manufacturing space.

Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Mr. Reddy serves as Chief Operating Officer, bringing over two and a half decades of experience in the pharmaceutical industry in new product development, pre-formulations, analytical R&D, and regulatory submissions. Before joining ScieGen, Mr. Reddy served as Associate Vice President at Aurobindo Pharma Limited in India, overseeing the research center in handling all kinds of sterile formulations. He has significant experience in Solid Oral dosages, liquids, and Parenterals. Mr. Reddy has also spent over 12 years with Dr. Reddy’s Laboratoriesas the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, and EU drug filings throughout the USA, Canada, and Europe and has several patents (the US and WO).He has also written several publications. Mr. Reddy holds an MS degree in Pharmacy from Dr. MGR Medical University in India.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Subba Reddy is the Associate Vice President and Head of Manufacturing Operations. He is responsible for the manufacturing and supply of pharmaceutical products, and leads a team of over 250 employees.
Mr. Reddy joined ScieGen in October, 2016 as Senior Director, and has extensive manufacturing background in achieving significant performance improvement with regards to deliveries, projects, and safety.

Prior to joining ScieGen, Mr. Reddy worked as a Manufacturing Plant Site Head atDr. Reddy’s Laboratories, Head of Operations atWockhardt, and Head of Production at Cipla. He has over 30 years of experience in the industry, and holds hold a bachelor degree in Pharmacy and management leadership certifications.

Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Mr. Reddy serves as Chief Operating Officer, bringing over two and a half decades of experience in the pharmaceutical industry in new product development, pre-formulations, analytical R&D, and regulatory submissions. Before joining ScieGen, Mr. Reddy served as Associate Vice President at Aurobindo Pharma Limited in India, overseeing the research center in handling all kinds of sterile formulations. He has significant experience in Solid Oral dosages, liquids, and Parenterals. Mr. Reddy has also spent over 12 years with Dr. Reddy’s Laboratoriesas the Associate Director of New Product Development in their Generic Pharmaceutical division. Mr. Reddy is responsible for almost 100 ANDA, NDA, and EU drug filings throughout the USA, Canada, and Europe and has several patents (the US and WO).He has also written several publications. Mr. Reddy holds an MS degree in Pharmacy from Dr. MGR Medical University in India.
Dr. Reddy is a graduate of Osmania University in India where he earned a BS degree in Chemistry with concentrations in genetics and botany. He later earned his Masters and Ph.D. in Organic Chemistry from Kanpur University.
Dr. Pailla Malla Reddy
Chief Executive Officer

Dr. Pailla Malla Reddy (CEO) is a successful pharmaceutical entrepreneur,he got abundant experience in various positions and managed pharmaceutical companies in Lagos, Nigeria, India and USA. Dr Reddy founded Sciegen Pharmaceuticals Inc. in 2009.

Sciegen operates a facility in Hauppuage, NY. Dr Reddy has successfully launched and actively manages other leading pharmaceutical companies in the USA and other countries as a Director.

He also founded Bactolac Pharmaceutical, Inc. in 1995 and has grown the company exponentially over the years. He also operates other companies in Russia. Dr. Reddy holds a Ph.D in Chemistry from Kanpur University in India. Under the eminent leadership and futuristic vision of Dr. Pailla Malla Reddy Chemeca Drugs Private Limited is set on the journey of transformation into world class Active Pharmaceutical and intermediate manufacturing facility.

At vero eos et accusamus et iusto odio digni goikussimos ducimus qui to bonfo blanditiis praese. Ntium voluum deleniti atque.

Melbourne, Australia
(Sat - Thursday)
(10am - 05 pm)

Metformin Hydrochloride Extended-Release Tablets, USP

NDC 50228-0446-90
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side I on the left sideand 07 on the right side of the bisect..
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glumetza®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-0177-01
Strength 600 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 177 on other side with bisect line on both sides
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Hydrochlorothiazide Capsules, USP

NDC 50228-0146-10
Strength 12.5 mg
Description of pill White to off-White powder filled in Size '4' Hard Gelatin Capsules with Opaque light blue colored cap and Opaque light colored body imprinted 'SG' on cap and '146' on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-Hypertensive
Brand Name Reference Microzide®
TE Code AB

Hydrochlorothiazide Capsules, USP

NDC 50228-0146-05
Strength 12.5 mg
Description of pill White to off-White powder filled in Size '4' Hard Gelatin Capsules with Opaque light blue colored cap and Opaque light colored body imprinted 'SG' on cap and '146' on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-Hypertensive
Brand Name Reference Microzide®
TE Code AB

Hydrochlorothiazide Capsules, USP

NDC 50228-0146-01
Strength 12.5 mg
Description of pill White to off-White powder filled in Size '4' Hard Gelatin Capsules with Opaque light blue colored cap and Opaque light colored body imprinted 'SG' on cap and '146' on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-Hypertensive
Brand Name Reference Microzide®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-0178-05
Strength 800 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 178 on other side with bisect line on both sides.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-0178-01
Strength 800 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 178 on other side with bisect line on both sides.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Tablets, USP

NDC 50228-0177-05
Strength 600 mg
Description of pill White to off white, Modified Capsule shape, biconvex tablets debossed SG on one side and 177 on other side with bisect line on both sides
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0181-05
Strength 400 mg
Description of pill White to Off white powder filled in size “0” hard gelatin capsules with opaque Orange colored cap and opaque Orange colored body imprinted “SG” on cap and “181” on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Levocetirizine Dihydrochloride Tablets, USP

NDC 50228-0136-90
Strength 5 mg
Description of pill White to off white, oval shaped, biconvex tablets de-bossed with S on the left side of bisect and G on the right side of bisect and other side '1' on the left side and 36 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-histamine
Brand Name Reference Xyzal®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0181-01
Strength 400 mg
Description of pill White to Off white powder filled in size “0” hard gelatin capsules with opaque Orange colored cap and opaque Orange colored body imprinted “SG” on cap and “181” on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0180-05
Strength 300 mg
Description of pill White to off white powder filled in size “1” hard gelatin capsules with opaque Yellow colored cap and opaque Yellow colored body imprinted “SG” on cap and “180” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0180-01
Strength 300 mg
Description of pill White to off white powder filled in size “1” hard gelatin capsules with opaque Yellow colored cap and opaque Yellow colored body imprinted “SG” on cap and “180” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0179-05
Strength 100 mg
Description of pill White to Off white powder filled in size “3” hard gelatin capsules with opaque White colored cap and opaque White colored body imprinted “SG” on cap and “179” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0179-01
Strength 100 mg
Description of pill White to Off white powder filled in size “3” hard gelatin capsules with opaque White colored cap and opaque White colored body imprinted “SG” on cap and “179” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-0421-01
Strength 20 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "421" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Levocetirizine Dihydrochloride Tablets, USP

NDC 50228-0136-30
Strength 5 mg
Description of pill White to off white, oval shaped, biconvex tablets de-bossed with S on the left side of bisect and G on the right side of bisect and other side '1' on the left side and 36 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-histamine
Brand Name Reference Xyzal®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0105-01
Strength 500 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed with "SG" on one side and "l05"on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-0421-30
Strength 20 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "421" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Nabumetone Tablets, USP

NDC 50228-0466-01
Strength 750 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘466’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Naproxen Tablets, USP

NDC 50228-0436-01
Strength 500 mg
Description of pill Light Yellow Oblong shaped tablets debossed with ''SG'' along with break-line on one side and ''436'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-0435-05
Strength 375 mg
Description of pill Light Yellow Capsule shaped tablets debossed with ''SG'' on one side and ''435'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-0435-01
Strength 375 mg
Description of pill Light Yellow Capsule shaped tablets debossed with ''SG'' on one side and ''435'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-0434-01
Strength 250 mg
Description of pill Light Yellow round shaped tablets debossed with ''SG'' along with break-line on one side and ''434'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Tablets, USP

NDC 50228-0434-05
Strength 250 mg
Description of pill Light Yellow round shaped tablets debossed with ''SG'' along with break-line on one side and ''434'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-0466-05
Strength 750 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘466’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-0465-05
Strength 500 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘465’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0105-05
Strength 500 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed with "SG" on one side and "l05"on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Nabumetone Tablets, USP

NDC 50228-0465-01
Strength 500 mg
Description of pill White colored, Oval shaped, Biconvex, film coated tablets, debossed with ‘SG’ on one side ‘465’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Relafen®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0107-10
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0107-05
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0107-01
Strength 1000 mg
Description of pill White to off white, oval shaped, biconvex tablets debossed with S on the left side of bisect and G on the right side of bisect and other side 1 on the left side and 07 on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0106-05
Strength 850 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed w'ith' 'SG' on one side and "106"on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0106-01
Strength 850 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed w'ith' 'SG' on one side and "106"on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Metformin Hydrochloride Tablets, USP

NDC 50228-0105-10
Strength 500 mg
Description of pill White to off white, round, biconvex, beveled edge tablets debossed with "SG" on one side and "l05"on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glucophage®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-0422-30
Strength 60 mg
Description of pill White to off white, Capsule shape film coated tablet with scored line on both sides debossed with “SG 422” on one side and plain on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Fluoxetine HCl by Alvogen
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-0420-01
Strength 10 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "420" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Naproxen Sodium Tablets, USP

NDC 50228-0432-01
Strength 275 mg (EQ 250 mg base)
Description of pill White, capsule shaped, film coated tablets, debossed with '432' on one side and 'SG' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Anaprox®
TE Code AB

Atorvastatin Calcium Tablets 40mg

NDC 50228-0453-10
Strength 40 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 154 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0175-05
Strength 150 mg
Description of pill Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0175-05
Strength 150 mg
Description of pill Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0174-05
Strength 100 mg
Description of pill Blue, round, biconvex, film coated tablets, debossed with 'SG, 174' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0174-01
Strength 100 mg
Description of pill Blue, round, biconvex, film coated tablets, debossed with 'SG, 174' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Atorvastatin Calcium Tablets 80mg

NDC 50228-0454-05
Strength 80 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 155 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 80mg

NDC 50228-0454-90
Strength 80 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 155 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 40mg

NDC 50228-0453-90
Strength 40 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 154 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0144-05
Strength 150 mg
Description of pill White to pale yellow, round, biconvex, film coated tablets, debossed with'144'on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Atorvastatin Calcium Tablets 20mg

NDC 50228-0452-05
Strength 20 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 153 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 20mg

NDC 50228-0452-90
Strength 20 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and 153 on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 10mg

NDC 50228-0451-10
Strength 10 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and '152' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Atorvastatin Calcium Tablets 10mg

NDC 50228-0451-90
Strength 10 mg
Description of pill Yellow, Oval Shape, Biconvex, Film Coated Tablets, Debossed with SG on one side and '152' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Lipid Lowering agent
Brand Name Reference Lipitor®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0176-60
Strength 200 mg
Description of pill Pink, round, biconvex, film coated tablets, debossed with oSG, 176' onone side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0175-60
Strength 150 mg
Description of pill Purple , round, biconvex tablets, debossed with 'SG 175' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin SR®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0144-30
Strength 150 mg
Description of pill White to pale yellow, round, biconvex, film coated tablets, debossed with'144'on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0145-30
Strength 300 mg
Description of pill White to pale yellow, Modified Capsule Shape, biconvex, film coated tablets, debossed with 145' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Fluoxetine Tablets, USP

NDC 50228-0420-30
Strength 10 mg
Description of pill White Modified oval shape scored tablets debossed with 'SG' on scored side and "420" on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-depressant
Brand Name Reference Prozac
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0113-01
Strength 10 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 4, Opaque Light Blue Colored Cap and Opaque Light Orange Colored Body imprinted with "SG" on Cap and "113" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0115-10
Strength 40 mg
Description of pill White to Off white powder filled in Hard Gelatin Capsules Size "0" with Opaque light blue colored cap and Opaque white colored body imprinted "SG" on cap and "115" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0115-01
Strength 40 mg
Description of pill White to Off white powder filled in Hard Gelatin Capsules Size "0" with Opaque light blue colored cap and Opaque white colored body imprinted "SG" on cap and "115" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0115-30
Strength 40 mg
Description of pill White to Off white powder filled in Hard Gelatin Capsules Size "0" with Opaque light blue colored cap and Opaque white colored body imprinted "SG" on cap and "115" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0114-10
Strength 20 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 2, Opaque Light Blue Colored Cap and Opaque Light Green Colored, Body imprinted with 'SG' on Cap and "114" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0114-01
Strength 20 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 2, Opaque Light Blue Colored Cap and Opaque Light Green Colored, Body imprinted with 'SG' on Cap and "114" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Fluoxetine Capsules, USP

NDC 50228-0113-10
Strength 10 mg
Description of pill White to Off white powder filled in Empty Hard Gelatin Capsule Size 4, Opaque Light Blue Colored Cap and Opaque Light Orange Colored Body imprinted with "SG" on Cap and "113" on Body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-depressant
Brand Name Reference Prozac®
TE Code AB

Ethacrynic acid Tablets, USP

NDC 50228-0334-01
Strength 25 mg
Description of pill White Capsule shaped, Scored Tablets, de bossed with SG on one side with score line and 334 on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Diuretic (Treatment of edema)
Brand Name Reference Edecrin®
TE Code AB

Bupropion Hydrochloride Extended- Release Tablets

NDC 50228-0145-05
Strength 300 mg
Description of pill White to pale yellow, Modified Capsule Shape, biconvex, film coated tablets, debossed with 145' on one side and plain on other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic Category Anti-depressant
Brand Name Reference Wellbutrin XL®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-0124-10
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-0124-05
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-0124-90
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Clopidogrel Tablets, USP

NDC 50228-0124-30
Strength 75 mg
Description of pill Pink colored, Round shaped, Bi convex film coated tablets de-bossed on one side with 'SG' and '124' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Antiplatelet
Brand Name Reference Plavix®
TE Code AB

Carisoprodol Tablets, USP

NDC 50228-0109-10
Strength 350 mg
Description of pill Round convex white tablets
de-bossed with SG 109 on one side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Muscle relaxant
Brand Name Reference Soma®
TE Code AA

Carisoprodol Tablets, USP

NDC 50228-0109-05
Strength 350 mg
Description of pill Round convex white tablets
de-bossed with SG 109 on one side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Muscle relaxant
Brand Name Reference Soma®
TE Code AA

Carisoprodol Tablets, USP

NDC 50228-0109-01
Strength 350 mg
Description of pill Round convex white tablets
de-bossed with SG 109 on one side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Muscle relaxant
Brand Name Reference Soma®
TE Code AA

Naproxen Tablets, USP

NDC 50228-0436-05
Strength 500 mg
Description of pill Light Yellow Oblong shaped tablets debossed with ''SG'' along with break-line on one side and ''436'' on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Naprosyn®
TE Code AB

Naproxen Sodium Tablets, USP

NDC 50228-0433-01
Strength 550 mg (EQ 500 mg base)
Description of pill White, capsule shaped, film coated tablets, debossed with '433' on one side and 'SG' along with break line on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Anaprox DS®
TE Code AB

Metformin Hydrochloride Extended-Release Tablets, USP

NDC 50228-0445-01
Strength 500 mg
Description of pill White to off white, oval shape, film coated tablets, debossed with “445” on one side and plain on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-diabetics
Brand Name Reference Glumetza®
TE Code AB

Hydralazine Hydrochloride Tablets

NDC 50228-183-01
Strength 25 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “183” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Levetiracetam Extended Release Tablets, USP

NDC 50228-0190-60
Strength 750 mg
Description of pill White to off white, Oval shape tablets debossed SG on one side and 190 on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of partial-onset seizures
Brand Name Reference KEPPRA XR®
TE Code AB

Levetiracetam Extended Release Tablets, USP

NDC 50228-0189-60
Strength 500 mg
Description of pill White to off white, Oval shape tablets debossed ‘SG’ on one side and ‘189’ on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of partial-onset seizures
Brand Name Reference KEPPRA XR®
TE Code AB

Hydralazine Hydrochloride Tablets

NDC 50228-185-01
Strength 100 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “185” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-184-10
Strength 50 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “184” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-184-01
Strength 50 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “184” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-183-10
Strength 25 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “183” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Hydralazine Hydrochloride Tablets

NDC 50228-182-10
Strength 10 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “182” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Pramipexole Dihydrochloride Tablets

NDC 50228-126-10
Strength 0.125 mg
Description of pill White to off white, round, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '126' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Hydralazine Hydrochloride Tablets

NDC 50228-182-01
Strength 10 mg
Description of pill Orange, round tablets debossed with “SG” on one side and “182” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention
Brand Name Reference Apresoline®
TE Code AA

Gabapentin Capsules, USP

NDC 50228-0180-10
Strength 300 mg
Description of pill White to off white powder filled in size “1” hard gelatin capsules with opaque Yellow colored cap and opaque Yellow colored body imprinted “SG” on cap and “180” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Gabapentin Capsules, USP

NDC 50228-0179-10
Strength 100 mg
Description of pill White to Off white powder filled in size “3” hard gelatin capsules with opaque White colored cap and opaque White colored body imprinted “SG” on cap and “179” on body with black ink
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anti-epileptic/ Management of postherpetic neuralgia
Brand Name Reference Neurontin®
TE Code AB

Ezetimibe Tablets, USP

NDC 50228-379-05
Strength 10 mg
Description of pill White to off white, Capsule shaped tablets embossed with “SG” on one side and “379” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-Hyperlipidemia
Brand Name Reference ZETIA®
TE Code AB

Ezetimibe Tablets, USP

NDC 50228-379-90
Strength 10 mg
Description of pill White to off white, Capsule shaped tablets embossed with “SG” on one side and “379” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-Hyperlipidemia
Brand Name Reference ZETIA®
TE Code AB

Ezetimibe Tablets, USP

NDC 50228-379-30
Strength 10 mg
Description of pill White to off white, Capsule shaped tablets embossed with “SG” on one side and “379” on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Anti-Hyperlipidemia
Brand Name Reference ZETIA®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-126-90
Strength 0.125 mg
Description of pill White to off white, round, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '126' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-127-90
Strength 0.25 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '27' on the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Droxidopa Capsules

NDC 50228-0430-90
Strength 200 mg
Description of pill Opaque Light yellow cap and Opaque white body, hard-gelatin capsule printed with black ink “SG” on the cap, “430” on the body.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic Category Treatment of orthostatic dizziness, lightheadedness, with symptomatic neurogenic orthostatic hypotension
Brand Name Reference Northera®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0457-01
Strength 10/100 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''457'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0459-05
Strength 25/250 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''459'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0459-01
Strength 25/250 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''459'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0458-10
Strength 25/100 mg
Description of pill Light yellow, Mottled, round, uncoated tablets debossed with "SG" on one side and ''458'' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0458-05
Strength 25/100 mg
Description of pill Light yellow, Mottled, round, uncoated tablets debossed with "SG" on one side and ''458'' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0458-01
Strength 25/100 mg
Description of pill Light yellow, Mottled, round, uncoated tablets debossed with "SG" on one side and ''458'' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Carbidopa and Levodopa Tablets, USP

NDC 50228-0457-05
Strength 10/100 mg
Description of pill Light blue, Mottled, round, uncoated tablets debossed with "SG" on one side and ''457'' on the other
OTC or Rx Rx
Dosage Form Tablets
Therapeutic Category Treatment of Parkinson's disease
Brand Name Reference SINEMET®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-131-10
Strength 1.5 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '31' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-127-10
Strength 0.25 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '27' on the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-131-90
Strength 1.5 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '31' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-130-10
Strength 1 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '30' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-130-90
Strength 1 mg
Description of pill White to off white, oval, flat, beveled edge un coated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '30' on the right side of the bisect.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-129-10
Strength 0.75 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '129' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-129-90
Strength 0.75 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets, debossed with 'SG' on one side '129' on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-128-10
Strength 0.5 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '28' on the other side. the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Pramipexole Dihydrochloride Tablets

NDC 50228-128-90
Strength 0.5 mg
Description of pill White to off white, oval, flat, beveled edge uncoated tablets debossed on one side with 'S' on the left side of bisect and 'G' on the right side of bisect and other side '1' on the left side and '28' on the other side. the right side of the bisect
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti-Parkinson’s - Dopamine Agonist
Brand Name Reference Mirapex®
TE Code AB

Droxidopa Capsules

NDC 50228-0431-90
Strength 300 mg
Description of pill Opaque Light Green cap and Opaque white body, hard-gelatin capsule printed with black ink “SG” on the cap, “431” on the body.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic Category Treatment of orthostatic dizziness, lightheadedness, with symptomatic neurogenic orthostatic hypotension
Brand Name Reference Northera®
TE Code AB

Droxidopa Capsules

NDC 50228-0429-90
Strength 100 mg
Description of pill Light blue cap and Opaque white body, hard-gelatin capsule printed with black ink "SG" on the cap, "429” on the body.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic Category Treatment of orthostatic dizziness, lightheadedness, with symptomatic neurogenic orthostatic hypotension
Brand Name Reference Northera®
TE Code AB

Naproxen Sodium Tablets, USP

NDC 50228-0433-05
Strength 550 mg(EQ 500 mg base)
Description of pill White, capsule shaped, film coated tablets, debossed with '433' on one side and 'SG' along with break line on other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Nonsteroidal anti-inflammatory drug (NSAID)
Brand Name Reference Anaprox DS®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0380-60
Strength 50 mg
Description of pill Peach, film coated, capsule-shaped, biconvex, embossed tablet with “380” on one side and plain on the other
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Ranolazine extended-release Tablets

NDC 50228-0424-60
Strength 1000 mg
Description of pill Pale yellow, oblong shaped, film-coated, extended release tablet debossed with “424” on one side and “SG” on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of chronic angina
Brand Name Reference Ranexa®
TE Code AB

Ranolazine extended-release Tablets

NDC 50228-0423-60
Strength 500 mg
Description of pill Peach, oblong shaped, film-coated, extended release tablet debossed with “423” on one side and “SG” on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of chronic angina
Brand Name Reference Ranexa®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0384-60
Strength 400 mg
Description of pill White, film coated, capsule shaped biconvex tablet embossing with 384 on one side and plain on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0383-60
Strength 300 mg
Description of pill Pale yellow, film coated, capsule shaped biconvex tablet embossing with 383 on one side and plain on the other side.
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0382-60
Strength 200 mg
Description of pill Yellow, film coated, capsule shaped biconvex tablet embossing with 382 on one side and plain on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Quetiapine Extended-Release Tablets, USP

NDC 50228-0381-60
Strength 150 mg
Description of pill White to off white, Capsule shaped biconvex tablets embossed with "381" on one side and plain on the other side
OTC or Rx Rx
Dosage Form Extended-release tablets
Therapeutic category Treatment of schizophrenia
Brand Name Reference Seroquel XR®
TE Code AB

Pregabalin Capsules

NDC 50228-0357-90
Strength 300 mg
Description of pill White to Off white powder filled in size"0" hard gelatin capsules with orange colored cap and white opaque colored body imprinted 'SG" on cap and"357" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Solifenacin Succinate Tablets

NDC 50228-0427-90
Strength 5 mg
Description of pill Light Yellow, Round Shape, film coated tablets, debossed with ' SG ' on one side '427' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Antimuscarinics
Brand Name Reference Vesicare®
TE Code AB

Pregabalin Capsules

NDC 50228-0356-90
Strength 225 mg
Description of pill White to Off white powder filled in size"l" hard gelatin capsules with light orange colored cap and white opaque colored body imprinted 'SG" on cap and"356" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Pregabalin Capsules

NDC 50228-0355-90
Strength 200 mg
Description of pill White to Off white powder filled in size"1" hard gelatin capsules with light orange colored cap and light orange colored body imprinted with "SG" on cap and "355" on the body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Pregabalin Capsules

NDC 50228-0354-90
Strength 150 mg
Description of pill White to Off white powder filled in size"2" hard gelatin capsules with white opaque colored cap and white opaque colored body imprinted with "SG" on cap and"354" on the body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Pregabalin Capsules

NDC 50228-0353-90
Strength 100 mg
Description of pill White to Off white powder filled in size''3" hard gelatin capsules with orange opaque colored cap and orange opaque colored body imprinted 'SG" on cap and"353" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Pregabalin Capsules

NDC 50228-0351-90
Strength 50 mg
Description of pill White to Off white powder filled in size 3 hard gelatin capsules with white opaque colored cap and white opaque colored body imprinted with "SG" on cap and "351" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Pregabalin Capsules

NDC 50228-0352-90
Strength 75 mg
Description of pill White to Off white powder filled in size"4" hard gelatin capsules with orange opaque colored cap and white opaque colored body imprinted with "SG" on cap and"352" on the body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Pregabalin Capsules

NDC 50228-0350-90
Strength 25 mg
Description of pill White to Off white powder filled in size "4" hard gelatin capsules with white opaque colored cap and white opaque colored body imprinted with "SG" on cap and "350" on body with black ink.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic category Anticonvulsant/Analgesics/Fibromyalgia
Brand Name Reference Lyrica®
TE Code AB

Solifenacin Succinate Tablets

NDC 50228-0427-30
Strength 5 mg
Description of pill Light Yellow,Round Shape, film coated tablets, debossed with ' SG ' on one side '427' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Antimuscarinics
Brand Name Reference Vesicare®
TE Code AB

Solifenacin Succinate Tablets

NDC 50228-0428-30
Strength 10 mg
Description of pill Light Pink,Round Shape, film coated tablets, debossed with ' SG ' on one side '428' on the other side.
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Antimuscarinics
Brand Name Reference Vesicare®
TE Code AB

Celecoxib Capsules

NDC 50228-1571-01
Strength 400 mg
Description of pill white capsules, with reverse printed white on green band with markings “SG” on cap and “159” on body.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic Category Anti-inflammatory
Brand Name Reference CELEBREX ®
TE Code AB

Olmesartan Medoxomil Tablets USP

NDC 50228-340-10
Strength 40 mg
Description of pill White, Oval, film-coated, tablet debossed with SG on one side and 341 on the other side
OTC or Rx Rx
Dosage Form Tablets
Therapeutic category Anti Hypertention -Angiotensin - II Receptor Blockers
Brand Name Reference Lipitor®
TE Code AB

Celecoxib Capsules

NDC 50228-1581-05
Strength 200 mg
Description of pill white capsules, with reverse printed white on gold band with markings “SG” on cap and “158” on body.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic Category Anti-inflammatory
Brand Name Reference CELEBREX ®
TE Code AB

Celecoxib Capsules

NDC 50228-1581-01
Strength 200 mg
Description of pill white capsules, with reverse printed white on gold band with markings “SG” on cap and “158” on body.
OTC or Rx Rx
Dosage Form Capsules
Therapeutic Category Anti-inflammatory
Brand Name Reference CELEBREX ®
TE Code AB